GSK Venture Capital Arm Goes Independent With $500m Fund

SR One Focused on Establishing Elite US And EU Biotechs

 
• By Kevin Grogan
  
GSK_HQ
SR One was GSK's VC ARM for 35 years • Source: Archive

More from Financing

More from Business